20 results on '"Porcheron, Marion"'
Search Results
2. Evaluation of two anti-SARS-CoV-2 antibody immunoassays for monitoring patients on pre-exposure prophylaxis
3. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
4. Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection
5. Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
6. Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
7. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
8. Weaker Effects of the Fourth Dose of BNT162b2 SARS-CoV-2 Vaccine on the Elderly Human Population.
9. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
10. Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection.
11. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration
12. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
13. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration
14. One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection
15. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
16. One year later
17. Strong Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Response of Previously Infected Healthcare Workers Given 1 Dose of mRNA Vaccine
18. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration.
19. Strong Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody Response of Previously Infected Healthcare Workers Given 1 Dose of mRNA Vaccine.
20. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.